Targeting dopamine receptor D2 as a novel therapeutic strategy in endometrial cancer.
Pierce SR, Fang Z, Yin Y, West L, Asher M, Hao T, Zhang X, Tucker K, Staley A, Fan Y, Sun W, Moore DT, Xu C, Tsai YH, Parker J, Prabhu VV, Allen JE, Lee D, Zhou C, Bae-Jump V.
Pierce SR, et al.
J Exp Clin Cancer Res. 2021 Feb 8;40(1):61. doi: 10.1186/s13046-021-01842-9.
J Exp Clin Cancer Res. 2021.
PMID: 33557912
Free PMC article.